Gardasil 9 syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FMTPT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,208
Award facts
- Contract value 100% obligated
- $10,208.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $10,208.04 firm fixed price delivery order to AmerisourceBergen Drug Corp for GARDASIL 9 vaccine syringes (0.5 mL) on June 18, 2025, with completion scheduled for June 20, 2025. This competitively awarded, non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999 pharmaceutical supply vehicle valued through December 2026 that supports military healthcare operations globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant federal contracting presence as a critical supplier to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of delivery orders through the DLA encompasses a wide range of pharmaceutical products and medical supplies, including vaccines, specialty medications, and medical devices across multiple therapeutic domains. This specific GARDASIL 9 procurement supports the Department of Defense's immunization requirements, consistent with the company's established role as a primary pharmaceutical vendor for federal military healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FMTPT?
SPE2DB25FMTPT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 18, 2025.
How much is contract SPE2DB25FMTPT worth?
The government has obligated $10,208 on SPE2DB25FMTPT.
Is contract SPE2DB25FMTPT an order under another contract?
Yes. SPE2DB25FMTPT is a delivery order under SPE2DB20D2104, an indefinite delivery contract.
Was contract SPE2DB25FMTPT competed?
The extent of competition for SPE2DB25FMTPT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award